Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novartis AG Common Stock
(NY:
NVS
)
155.49
-4.41 (-2.76%)
Official Closing Price
Updated: 4:10 PM EDT, Jul 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,918,262
Open
157.32
Bid (Size)
154.00 (200)
Ask (Size)
157.00 (200)
Prev. Close
159.90
Today's Range
154.21 - 157.57
52wk Range
112.34 - 170.46
Shares Outstanding
N/A
Dividend Yield
3.07%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5 Billion ADC Acquisition
Today 12:26 EDT
Via
Investor Brand Network
Novartis Scoops up UK Biotech Myricx in $1.5 Billion Cancer Push
↗
Today 11:13 EDT
Novartis acquires Myricx Bio for up to $1.5B to boost its oncology pipeline with a novel next-gen ADC cancer platform. Read more.
Via
Benzinga
Performance
YTD
+12.2%
+12.2%
1 Month
+4.2%
+4.2%
3 Month
+1.7%
+1.7%
6 Month
+12.7%
+12.7%
1 Year
+27.3%
+27.3%
More News
Read More
Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?
↗
July 04, 2026
Via
The Motley Fool
Topics
ETFs
New Research Says: The Biggest Gains of AI Won't Go to AI Stocks. These 2 ETFs Could Be Better Buys.
↗
July 04, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
IEFA vs. VXUS: Both Are Cheap. Both Are Broad. Here Is the Key Difference Long-Term Investors Need to Understand.
↗
July 02, 2026
Via
The Motley Fool
Topics
ETFs
3 European Stocks to Carry Investors Through the Back Half of 2026
↗
July 01, 2026
Via
MarketBeat
Topics
ETFs
Stocks
Core Restore Founder Ann Peets Announces Bladder Leak Treatments In Charleston
June 29, 2026
Via
Press Release Distribution Service
Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could
↗
June 29, 2026
Via
The Motley Fool
Novartis, Antares Partner To Pursue Undruggable Cancer Targets In $1.9 Billion Deal
↗
June 24, 2026
Via
Benzinga
The Quest to Repair What Multiple Sclerosis Takes Away
June 24, 2026
Via
Investor Brand Network
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis
June 24, 2026
Via
Investor Brand Network
The Quest to Repair What Multiple Sclerosis Takes Away
June 24, 2026
From
BioMedWire
Via
GlobeNewswire
Why I Think This Vanguard ETF Will Beat the S&P 500 Over the Next 10 Years
↗
June 20, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
Teva Just Delivered More Good News on Its Biggest Growth Driver. Is the Stock Still a Bargain?
↗
June 19, 2026
Via
The Motley Fool
Novartis' $12 Billion Bet Pays Off With Encouraging Data From Rare Neuromuscular Disease Study
↗
June 11, 2026
Via
Benzinga
IXUS vs. IEFA: Which International ETF Is Better for Most Investors?
↗
June 10, 2026
Via
The Motley Fool
Topics
ETFs
VXUS Has Delivered Better Returns Than IEFA Over the Past 5 Years. Should It Be in Your Portfolio?
↗
June 09, 2026
Via
The Motley Fool
Topics
ETFs
Arrowhead Pharmaceuticals Lines Up SHASTA Readout as REDEMPLO Launch Gains Traction
↗
June 05, 2026
Via
MarketBeat
IEFA: Why This Fund Is One of the Best International ETFs
↗
June 04, 2026
Via
The Motley Fool
Topics
ETFs
Dry eye syndrome drugs Market Size, Industry Report By 2035
↗
June 04, 2026
Via
Talk Markets
Topics
Economy
Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?
↗
June 02, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Adding a Healthcare Stock to Your Portfolio? FHLC Offers Broad Coverage While PPH Leads in Returns.
↗
June 02, 2026
Via
The Motley Fool
Topics
ETFs
CRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking
↗
June 01, 2026
Via
The Motley Fool
PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem
↗
May 27, 2026
Via
The Motley Fool
Topics
ETFs
Pediatrics Medicine Market Size, Industry Report By 2035
↗
May 22, 2026
Via
Talk Markets
Topics
Economy
Frequently Asked Questions
Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 155.49
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 07/06/26 04:10 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.